COMP <GO>
MIST vs RTSN // DIVIDEND YIELD & FCF PAYOUT SAFETY
Milestone Pharmaceuticals Inc. (NASDAQ) VS. Retension Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: MIST 1
— RTSN 1
■ METRIC PARITY
LAST: $0.76 (+5.30%) • MKT CAP: $89.8M
dividend-safety
0.00%
LAST: $11.79 (+4.34%) • MKT CAP: $89.1M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MIST VS. RTSN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MIST | RTSN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.9 | 55.4 | -11.45 | RTSN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $89.8M | $89.1M | $713.4K | MIST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MIST REV | RTSN REV | MIST GROSS % | RTSN GROSS % | MIST FCF | RTSN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $174.0M | — | — | — | -$49.3M | — |
| FY 2024 | $117.9M | — | — | — | -$28.9M | — |
| FY 2023 | $171.1M | — | — | — | -$46.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MIST // BETA —
RTSN // BETA —